CHARLES WYKOFF to Prevalence
This is a "connection" page, showing publications CHARLES WYKOFF has written about Prevalence.
Connection Strength
0.021
-
Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab: Findings from the TREX-AMD Trial. Ophthalmology. 2017 02; 124(2):215-223.
Score: 0.021